|
|
Medtronic Plc (NYSE: MDT) |
|
|
|
|
|
Medtronic Plc's Suppliers Performance
MDT's Supply Chain
| |
|
MDT Costs vs Sales of Suppliers Growth |
Medtronic Plc's Suppliers recorded an increase in sales by 2.09 % year on year in Q4 2024, from the previous quarter, sales fell by -3.17 %, Medtronic Plc's cost of sales deteriorated by -0.11 % year on year, relative to one quarter ago cost of sales fell by -5.67 % in Q4.
•
More on MDT Suppliers
|
|
|
Medtronic Plc's Suppliers recorded an increase in sales by 2.09 % year on year in Q4 2024, from the previous quarter, sales fell by -3.17 %, Medtronic Plc's cost of sales deteriorated by -0.11 % year on year, compare to one quarter ago cost of sales fell by -5.67 % in Q4.
•
More on MDT Suppliers
|
Select the Relationship:
|
|
Select the Category:
|
|
Medtronic Plc's Comment on Supply Chain
We manufacture most of our products at 41 manufacturing facilities located in
various countries throughout the world. The largest of these manufacturing facilities
are located in Arizona, California, Colorado, Connecticut, Florida, Indiana, Massachusetts,
Michigan, Minnesota, New Jersey, Texas, Puerto Rico, Canada, France, Germany,
Ireland, Italy, Mexico, The Netherlands, The Peoples Republic of China, Singapore,
and Switzerland. We purchase many of the components and raw materials used in
manufacturing these products from numerous suppliers in various countries. For
reasons of quality assurance, sole source availability, or cost effectiveness,
certain components and raw materials are available only from a sole supplier.
We work closely with our suppliers to help ensure continuity of supply while maintaining
high quality and reliability. Due to the U.S. FDA’s requirements regarding
manufacturing of our products, we may not be able to quickly establish additional
or replacement sources for certain components or materials. Generally, we have
been able to obtain adequate supplies of such raw materials and components. However,
a sudden or unexpected reduction or interruption in supply, and an inability to
develop alternative sources for such supply, could adversely affect our operations.
Moreover, as directed by the Dodd-Frank Wall Street Reform and Consumer Protection
Act (Dodd-Frank), the SEC has implemented reporting and disclosure requirements
related to the use of certain minerals, known as "conflict minerals":
tantalum, tin, tungsten (or their ores), and gold; which are mined from the Democratic
Republic of the Congo and adjoining countries. Pursuant to these requirements,
we are required to report on Form SD the procedures we employ to determine the
sourcing of such minerals and metals produced from those minerals. There are costs
associated with complying with these disclosure requirements, including for diligence
in regards to the sources of any conflict minerals used in our products, in addition
to the cost of remediation and other changes to products, processes, or sources
of supply as a consequence of such verification activities. In addition, the implementation
of these rules could adversely affect the sourcing, supply, and pricing of materials
used in our products. As of the date of our conflict minerals report for the 2013
calendar year, we were unable to obtain the necessary information on conflict
minerals from all of our suppliers and were unable to determine that all of our
products are conflict free. We may continue to face difficulties in gathering
this information in the future. We may face reputational challenges if we determine
that certain of our products contain minerals not determined to be conflict free
or if we are unable to sufficiently verify the origins for all conflict minerals
used in our products through the procedures we implement.
Medtronic Plc's Comment on Supply Chain
We manufacture most of our products at 41 manufacturing facilities located in
various countries throughout the world. The largest of these manufacturing facilities
are located in Arizona, California, Colorado, Connecticut, Florida, Indiana, Massachusetts,
Michigan, Minnesota, New Jersey, Texas, Puerto Rico, Canada, France, Germany,
Ireland, Italy, Mexico, The Netherlands, The Peoples Republic of China, Singapore,
and Switzerland. We purchase many of the components and raw materials used in
manufacturing these products from numerous suppliers in various countries. For
reasons of quality assurance, sole source availability, or cost effectiveness,
certain components and raw materials are available only from a sole supplier.
We work closely with our suppliers to help ensure continuity of supply while maintaining
high quality and reliability. Due to the U.S. FDA’s requirements regarding
manufacturing of our products, we may not be able to quickly establish additional
or replacement sources for certain components or materials. Generally, we have
been able to obtain adequate supplies of such raw materials and components. However,
a sudden or unexpected reduction or interruption in supply, and an inability to
develop alternative sources for such supply, could adversely affect our operations.
Moreover, as directed by the Dodd-Frank Wall Street Reform and Consumer Protection
Act (Dodd-Frank), the SEC has implemented reporting and disclosure requirements
related to the use of certain minerals, known as "conflict minerals":
tantalum, tin, tungsten (or their ores), and gold; which are mined from the Democratic
Republic of the Congo and adjoining countries. Pursuant to these requirements,
we are required to report on Form SD the procedures we employ to determine the
sourcing of such minerals and metals produced from those minerals. There are costs
associated with complying with these disclosure requirements, including for diligence
in regards to the sources of any conflict minerals used in our products, in addition
to the cost of remediation and other changes to products, processes, or sources
of supply as a consequence of such verification activities. In addition, the implementation
of these rules could adversely affect the sourcing, supply, and pricing of materials
used in our products. As of the date of our conflict minerals report for the 2013
calendar year, we were unable to obtain the necessary information on conflict
minerals from all of our suppliers and were unable to determine that all of our
products are conflict free. We may continue to face difficulties in gathering
this information in the future. We may face reputational challenges if we determine
that certain of our products contain minerals not determined to be conflict free
or if we are unable to sufficiently verify the origins for all conflict minerals
used in our products through the procedures we implement.
|
MDT's Suppliers Net Income grew by |
MDT's Suppliers Net margin grew in Q4 to |
|
4.39 % |
7.37 % |
|
MDT's Suppliers Net Income grew by 4.39 % |
MDT's Suppliers Net margin grew in Q4 to 7.37 % |
MDT's vs. Suppliers, Data
(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)
| COMPANY NAME |
MARKET CAP |
REVENUES |
INCOME |
EMPLOYEES |
|
Medtronic Plc
|
113,532.87 |
33,199.00 |
4,290.00 |
100,000 |
|
3m Company
|
79,641.06 |
24,513.00 |
4,377.00 |
85,000 |
|
A negative correlation coefficient of -0.369 implies that the revenue of 3m Company does not correlate significantly with that of Medtronic Plc. |
|
Alcoa Corp
|
7,571.40 |
12,665.00 |
879.00 |
13,600 |
|
The factor of 0.426 indicates a mild correlation between Alcoa Corp's revenue and those of Medtronic Plc. |
|
Ati Inc
|
12,194.49 |
4,464.10 |
414.80 |
7,300 |
|
Ati Inc 's revenue correlates notably with that of Medtronic Plc. The correlation coefficient is 0.523 |
|
Chevron Corp
|
252,864.29 |
201,686.00 |
15,710.00 |
29,138 |
|
A negative correlation coefficient of -0.217 implies that the revenue of Chevron Corp does not correlate significantly with that of Medtronic Plc. |
|
Dow Inc
|
21,687.69 |
42,630.00 |
373.00 |
35,900 |
|
The factor of 0.274 indicates a mild correlation between Dow Inc 's revenue and those of Medtronic Plc. |
|
Eastman Chemical Co
|
9,167.24 |
9,362.00 |
926.00 |
14,500 |
|
The revenue of Eastman Chemical Co does not correlate significantly with that of Medtronic Plc. The correlation coefficient is 0.057 |
|
Exxon Mobil Corporation
|
480,360.82 |
349,632.00 |
34,530.00 |
62,000 |
|
A negative correlation coefficient of -0.204 implies that the revenue of Exxon Mobil Corporation does not correlate significantly with that of Medtronic Plc. |
|
Illinois Tool Works Inc
|
72,433.89 |
15,764.00 |
3,369.00 |
45,000 |
|
The revenue of Illinois Tool Works Inc does not correlate significantly with that of Medtronic Plc. The correlation coefficient is 0.041 |
|
Worthington Enterprises Inc
|
3,036.85 |
2,858.74 |
195.22 |
9,220 |
|
A negative correlation coefficient of -0.164 implies that the revenue of Worthington Enterprises Inc does not correlate significantly with that of Medtronic Plc. |
|
Nlight Inc
|
884.66 |
204.33 |
-55.12 |
1,271 |
|
A negative correlation coefficient of -0.084 implies that the revenue of Nlight Inc does not correlate significantly with that of Medtronic Plc. |
|
Helen Of Troy Limited
|
655.40 |
1,907.41 |
123.75 |
2,498 |
|
A negative correlation coefficient of -0.393 implies that the revenue of Helen Of Troy Limited does not correlate significantly with that of Medtronic Plc. |
|
Arconic Corporation
|
3,050.71 |
8,141.00 |
-254.00 |
13,000 |
|
A negative correlation coefficient of -0.179 implies that the revenue of Arconic Corporation does not correlate significantly with that of Medtronic Plc. |
|
Haynes International inc
|
785.80 |
613.50 |
37.51 |
900 |
|
Haynes International inc 's revenue correlates notably with that of Medtronic Plc. The correlation coefficient is 0.654 |
|
Universal Stainless and Alloy Products Inc
|
447.32 |
325.47 |
26.65 |
622 |
|
The revenue of Universal Stainless and Alloy Products Inc does not correlate significantly with that of Medtronic Plc. The correlation coefficient is 0.164 |
|
Solitario Resources Corp
|
56.37 |
0.32 |
-5.15 |
15 |
|
A negative correlation coefficient of -0.014 implies that the revenue of Solitario Resources Corp does not correlate significantly with that of Medtronic Plc. |
|
Ingevity Corporation
|
1,630.12 |
1,350.70 |
-353.80 |
1,700 |
|
A negative correlation coefficient of -0.086 implies that the revenue of Ingevity Corporation does not correlate significantly with that of Medtronic Plc. |
|
Stepan Company
|
1,271.07 |
2,221.40 |
56.19 |
2,389 |
|
The factor of 0.224 indicates a mild correlation between Stepan Company's revenue and those of Medtronic Plc. |
|
Trinseo Plc
|
117.55 |
3,556.60 |
-704.80 |
3,100 |
|
Trinseo Plc's revenue correlates notably with that of Medtronic Plc. The correlation coefficient is 0.449 |
|
Vystar Corporation
|
1.19 |
0.15 |
-6.60 |
202 |
|
|
|
Dmc Global Inc
|
158.33 |
635.42 |
-152.42 |
314 |
|
The factor of 0.202 indicates a mild correlation between Dmc Global Inc 's revenue and those of Medtronic Plc. |
|
Liquidmetal Technologies Inc
|
100.90 |
0.97 |
-1.77 |
18 |
|
A negative correlation coefficient of -0.239 implies that the revenue of Liquidmetal Technologies Inc does not correlate significantly with that of Medtronic Plc. |
|
Mueller Industries Inc
|
8,860.32 |
3,919.28 |
635.12 |
4,509 |
|
Mueller Industries Inc's revenue correlates notably with that of Medtronic Plc. The correlation coefficient is 0.484 |
|
Materion Corporation
|
1,703.99 |
1,718.95 |
10.18 |
2,224 |
|
The revenue of Materion Corporation does not correlate significantly with that of Medtronic Plc. The correlation coefficient is 0.136 |
|
Ryerson Holding Corporation
|
661.42 |
4,495.20 |
-5.20 |
2,400 |
|
The revenue of Ryerson Holding Corporation does not correlate significantly with that of Medtronic Plc. The correlation coefficient is 0.109 |
|
Calumet Inc
|
1,222.97 |
4,176.90 |
-342.40 |
202 |
|
A negative correlation coefficient of -0.077 implies that the revenue of Calumet Inc does not correlate significantly with that of Medtronic Plc. |
|
Couchbase Inc
|
1,039.64 |
184.98 |
-76.87 |
792 |
|
The revenue of Couchbase Inc does not correlate significantly with that of Medtronic Plc. The correlation coefficient is 0.004 |
|
Ipg Photonics Corp
|
2,911.29 |
951.43 |
-201.87 |
6,180 |
|
A negative correlation coefficient of -0.014 implies that the revenue of Ipg Photonics Corp does not correlate significantly with that of Medtronic Plc. |
|
Lightpath Technologies Inc
|
118.71 |
33.63 |
-10.17 |
316 |
|
Lightpath Technologies Inc 's revenue correlates notably with that of Medtronic Plc. The correlation coefficient is 0.466 |
|
Viavi Solutions Inc
|
2,126.05 |
1,046.20 |
5.10 |
3,600 |
|
Viavi Solutions Inc 's revenue correlates notably with that of Medtronic Plc. The correlation coefficient is 0.482 |
|
Mongodb Inc
|
17,071.41 |
1,781.64 |
-133.63 |
2,819 |
|
The revenue of Mongodb Inc does not correlate significantly with that of Medtronic Plc. The correlation coefficient is 0.084 |
|
Elastic N v
|
8,646.00 |
1,482.42 |
-108.11 |
3,187 |
|
The revenue of Elastic N v does not correlate significantly with that of Medtronic Plc. The correlation coefficient is 0.140 |
|
Wolfspeed Inc
|
220.07 |
759.50 |
-1,512.90 |
5,013 |
|
The factor of 0.235 indicates a mild correlation between Wolfspeed Inc 's revenue and those of Medtronic Plc. |
|
Eltek Ltd
|
66.18 |
46.53 |
4.22 |
841 |
|
The revenue of Eltek Ltd does not correlate significantly with that of Medtronic Plc. The correlation coefficient is 0.001 |
|
Interlink Electronics inc
|
59.09 |
10.54 |
-2.45 |
102 |
|
The revenue of Interlink Electronics inc does not correlate significantly with that of Medtronic Plc. The correlation coefficient is 0.048 |
| SUBTOTAL |
992,824.28 |
703,139.30 |
57,745.49 |
359,872 |
News about
Medtronic Plc Contracts
|
|
1.11 %